ArriVent BioPharma (AVBP) Cash from Investing Activities (2025 - 2026)
ArriVent BioPharma (AVBP) reported Cash from Investing Activities of $3.6 million for Q1 2026, down 90.27% on a YoY basis from $36.8 million in Q1 2025, and up 105.03% sequentially from -$71.2 million in Q4 2025.
ArriVent BioPharma (AVBP) Cash from Investing Activities (2025 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 2 years of Cash from Investing Activities data on file, last reported at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 90.27% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$104.5 million (changed N/A YoY), and the FY2025 full-year result was -$71.2 million, up 62.99% from the prior year.
- Cash from Investing Activities rose to $3.6 million in Q1 2026, from -$71.2 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $36.8 million in Q1 2025 to a low of -$71.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | -25.54 Mn |
| 10 | ArriVent BioPharma | 1.40 Bn | 1.40 Bn | - | 3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Mn |
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | -71.20 Mn |
| Dec 31, 2025 | -71.20 Mn |
| Sep 30, 2025 | -50.76 Mn |
| Sep 30, 2025 | -50.76 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Jun 30, 2025 | 13.91 Mn |
| Mar 31, 2025 | 36.82 Mn |
| Mar 31, 2025 | 36.82 Mn |